PKO Investment Management Joint-Stock’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$543K Buy
6,000
+700
+13% +$58.6K 0.04% 195
2026
Q1
$424K Sell
5,300
-1,200
-18% -$98.9K 0.04% 190
2025
Q4
$554K Sell
6,500
-3,000
-32% -$246K 0.04% 185
2025
Q3
$739K Sell
9,500
-500
-5% -$39.1K 0.06% 159
2025
Q2
$782K Sell
10,000
-7,000
-41% -$522K 0.08% 141
2025
Q1
$1.23M Buy
17,000
+9,000
+113% +$644K 0.14% 109
2024
Q4
$592K Sell
8,000
-6,000
-43% -$420K 0.07% 133
2024
Q3
$924K Buy
14,000
+8,000
+133% +$581K 0.11% 115
2024
Q2
$554K Buy
6,000
+3,500
+140% +$310K 0.07% 142
2024
Q1
$240K Sell
2,500
-12,500
-83% -$1.05M 0.03% 156
2023
Q4
$1.14M Sell
15,000
-5,000
-25% -$348K 0.14% 97
2023
Q3
$1.39M Buy
20,000
+12,800
+178% +$1.03M 0.19% 77
2023
Q2
$679K Hold
7,200
0.08% 126
2023
Q1
$596K Hold
7,200
0.08% 124
2022
Q4
$537K Hold
7,200
0.08% 115
2022
Q3
$595K Hold
7,200
0.1% 108
2022
Q2
$685K Sell
7,200
-3,278
-31% -$339K 0.1% 104
2022
Q1
$1.23M Hold
10,478
0.15% 94
2021
Q4
$1.36M Buy
+10,478
New +$1.22M 0.15% 90

Other funds holding EW

PKO Investment Management Joint-Stock's EW Position: Q2 2026 in Review

PKO Investment Management Joint-Stock increased its Edwards Lifesciences (EW) stake by 13% in Q2 2026, buying an estimated $58.6K and bringing the position to 6,000 shares worth $543K. The position accounts for 0.04% of the portfolio, ranked #195.

PKO Investment Management Joint-Stock first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.39M in Q3 2023. 458 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • PKO Investment Management Joint-Stock held 6,000 shares of Edwards Lifesciences worth $543K as of Q2 2026.
  • PKO Investment Management Joint-Stock bought 700 Edwards Lifesciences shares in Q2 2026, an estimated $58.6K.
  • Edwards Lifesciences made up 0.04% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #195 holding.
  • PKO Investment Management Joint-Stock first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
  • PKO Investment Management Joint-Stock's Edwards Lifesciences position peaked at $1.39M in Q3 2023.
  • 458 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.